SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (300)1/30/1999 4:10:00 PM
From: Arthur Radley  Read Replies (2) of 626
 
Rick,
I think TTP is looking more interesting every day. My one concern(actually many biotechs could only wish to have this problem)is that they have tooooo many irons in the fire.... Parkinson's disease, cancer and the deal with Novartis. I don't want them to get in the same category of LGND and have to dilution the "hell" out of the shareholders value to get additional funding. I would like to think that the Novartis deal will bridge them into a cash flow situation that will avoid this with Pivanex and Spermamine.
I guess I shouldn't complain about LGND as I have a nice profit with the 5,000 shares I currently hold, but I want more out of this company than a 13.00 dollar stock.

What are your thoughts on the XOMA funding this week? Between my investments in XOMA and TTP, how many sleepless nights can I afford!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext